weekly semaglutide injections Another Weight-Loss Trial Win for GLP-1 Drug Once-Weekly Semaglutide in Adults with

This comparison breaks down how retatrutide and tirzepatide differ, what current clinical data shows, and which type of patient each may be better suited for

Promising effects beyond weight loss Researchers are currently studying the effect of GLP-1s on a wide range of conditions beyond diabetes, obesity, and heart disease, including renal, hepatic, neurological, and substance-use disorders

The consequence of short half-lives A defining practical feature of both peptides is that they are short-acting

bioRxiv Fatty Acid Transport Protein-2 (FATP2) Inhibition Enhances Glucose Tolerance through -Cell-mediated GLP-1 Secretion